Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
RANDOMIZED CONTROLLED TRIAL
Gail L Daumit, Faith B Dickerson, Nae-Yuh Wang, Arlene Dalcin, Gerald J Jerome, Cheryl A M Anderson, Deborah R Young, Kevin D Frick, Airong Yu, Joseph V Gennusa, Meghan Oefinger, Rosa M Crum, Jeanne Charleston, Sarah S Casagrande, Eliseo Guallar, Richard W Goldberg, Leslie M Campbell, Lawrence J Appel
BACKGROUND: Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness. METHODS: We recruited overweight or obese adults from 10 community psychiatric rehabilitation outpatient programs and randomly assigned them to an intervention or a control group...
April 25, 2013: New England Journal of Medicine
#2
REVIEW
Arianna Goracci, Silvia di Volo, Francesco Casamassima, Simone Bolognesi, Jim Benbow, Andrea Fagiolini
OBJECTIVES: The purpose of this article is to provide a comprehensive review of pharmacotherapy for binge eating disorder, including new therapeutic approaches such as centrally acting sympathomimetics, nootropics, lisdexamfetamine, and substance abuse treatment agents such as acamprosate, sodium oxybate, baclofen, and naltrexone. METHODS: The study was conducted by searching the MEDLINE database using the keywords "binge eating disorder," "obesity," and "pharmacological therapy...
January 2015: Journal of Addiction Medicine
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
